Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome (Episas)

February 9, 2021 updated by: University Hospital, Grenoble
This prospective study aims to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.

Study Overview

Detailed Description

Polysomnography is the gold-standard for obstructive sleep apnea (OSA) diagnosis. However, OSA is still undiagnosed. Maxillofacial profile can influence OSA severity. Morphological characteristics can be identified but are not enough measurable and analysable by physicians. 3D acquisition of maxillofacial characteristics with a user-friendly tool, quick and low-priced could be used to obtain a predictive model as an OSA risk indicator. Thus, the aim of this study is to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.

Study Type

Interventional

Enrollment (Actual)

280

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Grenoble, France
        • Grenoble Alpes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • BMI < 35 kg/m²
  • caucasian men
  • patients from the sleep laboratory (CHU Grenoble Alpes) admitted for a polysomnography
  • Patient who has given free and informed consent in writing

Exclusion Criteria:

  • history of maxillofacial surgery
  • dental malocclusion
  • patient involved in another clinical research study
  • patient not affiliated with social security
  • patient deprived of liberty or hospitalized without consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: OSA diagnosis with 3D acquisition
A 3D acquisition of maxillofacial characteristics will be performed for each patient in order to validate a predictive model comparable to data obtained by polysomnography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Establish and evaluate a predictive model for OSA diagnosis by 3D acquisition of characteristics maxillofacial
Time Frame: 1 measure at inclusion
apnea hypopnea index will be measured by polysomnography for each patient and compared to a predictive model establish from body mass index and 3D acquisition (cricomental distance...)
1 measure at inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity study from different stages of OSA severity
Time Frame: 1 measure at inclusion
OSA severity stages will be apnea hypopnea index <5, <10, <15
1 measure at inclusion
Compare diagnosis performances of predictive model and Berlin or NoSAS questionnaires
Time Frame: 1 measure at inclusion
Correlation between the Berlin or NoSAS score and the predictive model results
1 measure at inclusion
Evaluate performances of the combination (Berlin questionnaire + predictive model) to estimate the OSA risk
Time Frame: 1 measure at inclusion
Calculate the sensitivity, specificity, predictive positive value and predictive negative value of the combination
1 measure at inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Louis PEPIN, Chu Grenoble Alpes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 27, 2018

Primary Completion (Actual)

July 27, 2018

Study Completion (Actual)

September 8, 2020

Study Registration Dates

First Submitted

August 13, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 15, 2018

Study Record Updates

Last Update Posted (Actual)

February 10, 2021

Last Update Submitted That Met QC Criteria

February 9, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

Clinical Trials on 3D acquisition of maxillofacial characteristics

3
Subscribe